Scholars Central

Research articlePublished 15 Mar 2017

Analysis of efficacy and safety of treatment of active rheumatoid arthritis with iguratimod and methotrexate

Authors: Ling Zhao, Zhenyu Jiang, Yandong Zhang, Hongshuang Ma, Chunlei Cai

Biomedical Research

Volume 28 · Issue 5 · Pages 2353–2359

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Iguratimod (IGU) has been suggested to be a novel and useful DMARD with a unique mechanism of action. It is much less expensive than biologics. We evaluated and compared the efficacy and safety of IGU, methotrexate (MTX), and IGU+MTX for the treatment of rheumatoid arthritis (RA). RA patients were randomly divided into three groups: IGU+MTX, placebo+IGU and placebo+MTX group. Relevant laboratory parameters were periodically reviewed and clinical outcome measures were assessed after 4, 8, 12, 16 and 24 weeks. Symptoms of all patients significantly improved after treatment. After four weeks of treatment, differences in American College of Rheumatology 20% improvement criteria response rate (ACR20) between any of the groups were not significant. However, ACR20 response rate improved more in the MTX+IGU group compared to the monotherapy groups. After 24 weeks of treatment, combined treatment with IGU and MTX was superior to monotherapy with either IGU or MTX. There were no significant differences between the incidences of adverse effects among the three treatment groups. In conclusion: The treatment of RA with IGU is effective, and the effect of IGU treatment becomes apparent earlier than MTX treatment. To some extent, the combination of IGU and MTX results in an additive therapeutic effect. IGU+MTX maybe used as first-line treatment instead of MTX.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Biomedical Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiomedical Research
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Ling Zhao”
  • BylineArticles whose byline prints “Zhenyu Jiang”
  • BylineArticles whose byline prints “Yandong Zhang”
  • BylineArticles whose byline prints “Hongshuang Ma”
  • BylineArticles whose byline prints “Chunlei Cai”